RELATIONSHIP OF OXIDATIVE STRESS WITH THE INDICATORS OF BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND OSTEOPOROSIS
The literature data indicate that there is a close relationship between carbohydrate metabolism and bone metabolism in patients with type 2 diabetes mellitus (DM). It is important to find the factors that lead to changes in bone turnover in patients with type 2 DM. One of these factors may be oxidative stress (OS).
The purpose of the study analysis of the relationship between the parameters of bone metabolism and oxidative stress in patients with a combined course of diabetes mellitus type 2 and osteoporosis (OP).
Materials and methods. Study of 94 patients, of which 1-st group – 22 patients with OP, 2-nd group – 22 patients with type 2 DM, 3-rd group – 50 patients with combined course of these diseases. An ultrasound densitometry on an Omnisense 7000 ultrasound densitometer (BeamMedLtd, Israel) was performed for all patients. The bone tissue assessment been performed according to the WHO criteria. The levels of osteocalcin (OK), parathyroid hormone, calcitonin in blood serum, the level deoxypyridinoline (DPD) was determined in morning urine for all patients. The OS intensity was assessed by the nitrotyrosine level in the serum.
Results. In patients with a combined course of type 2 diabetes and OP bone metabolism, there is a significant reduction in the levels of OC and DPD by 44 % and 24 % compared to patients who did not have type 2 DM (p < 0.05). In patients with a combined course of type 2 DM and OP, the severity of the OS increases, which is confirmed by a significant increase in the level of nitrotyrosine in 2.8 times compared with patients with OP and 2.1 times – with type 2 DM (p < 0,05). In patients with combined course of type 2 DM and OP recorded negative relationship between bone metabolism and OS, as evidenced by the presence of significant association between levels nitrotyrosine, OC, DPD, parathyroid hormone and calcitonin.
Conclusion. The relationship between nitrotyrosine and indicators of bone metabolism may indicate the significant role of reactive oxygen species in decreasing bone turnover in patients with combined course of type 2 DM and OP.
2. Kanazawa І. (2017). Interaction between bone and glucose metabolism Endocrine Journal. 64. 1043-1053. doi.org/10.1507/endocrj.EJ17-0323.
3. Qian Wu, Zhao-Ming Zhong, Ying Pan, et al. (2015) Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis. Medical science monitor, 21, 2428–2432. doi: 10.12659/MSM.894347
4. Makurina GI. (2015) Nitroziruyushchiy stress pri psoriaticheskoy bolezni v sochetanii s essentsial'noy gipertenziyey [Nitrosative Stress in Psoriatic Diseases Combined with Essential Hypertension.] Vestnik problem biologii i meditsiny, №3, 159-165. [in Russian].
5. Azizova GI, Dadashova AR, Amirova MF. (2014). Biomarkery oksidativnogo stressa i sostoyaniye antioksidantnoy sistemy pri sakharnom diabete tipa 2 [Biomarkers of oxidative stress and the state of the antioxidant system in type 2 diabetes mellitus] Universum: Meditsina i farmakologiya: elektron. nauchn. Zhurn, 6(7). Retrieved from: http://7universum.com/ru/med/archive/item/1386. [in Russian].
6. Vinnik YuS, Kochetova LV, Kulikova AB. (2013). Ul'trazvukovaya densitometriya v diagnostike osteoartropatii u bol'nykh sakharnym diabetom [Ultrasonic densitometry in diagnocs of the osteoarthropathy at sick of the diabetes]. Kubanskiy nauchnyy meditsinskiy vestnik. 4.(139). 28-31.
7. Starup-Linde J. (2013). Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone. Front Endocrinol (Lausanne). 4. 21. doi: 10.3389/fendo.2013.00021.
8. Yamamoto M, Yamaguchi Т, Nawata К, et al. (2012). Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab., 97(4), 1277-84. doi: 10.1210/jc.2011-2537.
9. Al-Hariri M. (2016). Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes. J Diabetes Res. doi: 10.1155/2016/6969040
10. Gendeleka GF. (2011). Antioksidantnaya terapiya s pomoshch'yu A-lipoyevoy kisloty (tiogammy) [Antioxidant Therapy with A-Lipoic Acid (Thiogamma)]. Mezhdunarodnyy endokrinologicheskiy zhurnal, 5 (37), 63-68. [in Russian].
11. Zanozina OV. (2010). Vozmozhnosti korrektsii okislitel'nogo stressa u bol'nykh sakharnym diabetom s pomoshch'yu dibikora. [Possibilities of correcting oxidative stress in patients with diabetes mellitus using dibicor]. Farmateka, 16, 73-76. [in Russian].
12. Gennari L, Merlotti D, Valenti R, Ceccarelli Е et al. (2012). Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism., 97, 1737–1744.
13. Zhou Q, Zhu L, Zhang D, Li N, et al. (2016). Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analyses. Dis Markers., Retrieved from: http://dx.doi.org/10.1155/2016/7067984
14. Zaytseva OV, Shandarenko SH, Velykyy MM. (2015). Vplyv nitrozatyvnoho stresu na mineralʹnyy metabolizm kistkovoyi tkanyny shchuriv za umov alimentarnoho osteoporozu [Influence of nitrosatitative stress on the mineral metabolism of bone tissue of rats under conditions of alimentary osteoporosis]. Medychna ta klinichna khimiya, 17, 1, 5-11. [in Ukrainian].
This work is licensed under a Creative Commons Attribution 4.0 International License.